Agrium and PotashCorp Provide Update on Approvals for Proposed Merger of Equals

CALGARY, AB and SASKATOON, SK—(Marketwired – November 07, 2016) – Agrium Inc. (TSX: AGU) (NYSE: AGU) and Potash Corporation of Saskatchewan Inc. (PotashCorp) (TSX: POT) (NYSE: POT) advised that the Ontario Superior Court of Justice has issued a final order approving their merger of equals transaction to be implemented by way of a plan of arrangement under the Canada Business Corporations Act. As previously announced, shareholders of both companies overwhelmingly voted to approve the proposed merger of equals.

The companies have made good progress with respect to making all required regulatory filings and as expected, have received a supplemental information request from the Canadian Competition Bureau and a second request from the U.S. Federal Trade Commission on November 2, 2016. Agrium and PotashCorp are working through the regulatory process as planned and continue to expect the transaction to close mid–2017, subject to the satisfaction of customary closing conditions, including receipt of regulatory approvals.

About Agrium

Agrium Inc. is a major global producer and distributor of agricultural products, services and solutions. Agrium produces nitrogen, potash and phosphate fertilizers, with a combined wholesale nutrient capacity of over nine million tonnes and with significant competitive advantages across our product lines. We supply key products and services directly to growers, including crop nutrients, crop protection, seed, as well as agronomic and application services, thereby helping growers to meet the ever growing global demand for food and fibre. Agrium retail–distribution has an unmatched network of over 1,400 facilities and over 3,800 crop consultants who provide advice and products to our grower customers to help them increase their yields and returns on hundreds of different crops. With a focus on sustainability, the company strives to improve the communities in which it operates through safety, education, environmental improvement and new technologies such as the development of precision agriculture and controlled release nutrient products. Agrium is focused on driving operational excellence across our businesses, pursuing value–enhancing growth opportunities and returning capital to shareholders. For more information visit:

About PotashCorp

PotashCorp is the world's largest crop nutrient company and plays an integral role in global food production. The company produces the three essential nutrients required to help farmers grow healthier, more abundant crops. With global population rising and diets improving in developing countries, these nutrients offer a responsible and practical solution to meeting the long–term demand for food. PotashCorp is the largest producer, by capacity, of potash and one of the largest producers of nitrogen and phosphate. While agriculture is its primary market, the company also produces products for animal nutrition and industrial uses. Common shares of Potash Corporation of Saskatchewan Inc. are listed on the Toronto Stock Exchange and the New York Stock Exchange.


Certain statements and other information included in this press release constitute “forward–looking information” or “forward–looking statements” (collectively, “forward–looking statements”) under applicable securities laws. All statements in this press release, other than those relating to historical information or current conditions, are forward–looking statements, including, but not limited to, statements as to Agrium and PotashCorp management's expectations with respect to the proposed combination of Agrium and PotashCorp (the “transaction”) under a new parent company. This press release also contains forward–looking statements regarding the anticipated completion of the transaction and timing thereof. Forward–looking statements in this press release are based on certain key expectations and assumptions made by Agrium and PotashCorp, including expectations and assumptions concerning the receipt, in a timely manner, of regulatory and stock exchange approvals in respect of the transaction. Although Agrium and PotashCorp believe that the expectations and assumptions on which such forward–looking statements are based are reasonable, undue reliance should not be placed on the forward–looking statements because Agrium and PotashCorp can give no assurance that they will prove to be correct. Forward–looking statements are subject to various risks and uncertainties which could cause actual results and experience to differ materially from the anticipated results or expectations expressed in this press release. The key risks and uncertainties include, but are not limited to governmental and regulatory requirements and actions by governmental authorities, including changes in government policy, government ownership requirements, changes in environmental, tax and other laws or regulations and the interpretation thereof; and other risk factors detailed from time to time in Agrium and PotashCorp reports filed with the Canadian securities regulatory authorities and the United States Securities and Exchange Commission. There are also risks that are inherent in the nature of the transaction, including failure to obtain any required regulatory and other approvals (or to do so in a timely manner). The anticipated timeline for completion of the transaction may change for a number of reasons, including the inability to secure necessary regulatory, stock exchange or other approvals in the time assumed or the need for additional time to satisfy the conditions to the completion of the transaction. As a result of the foregoing, readers should not place undue reliance on the forward–looking statements contained in this press release concerning the timing of the transaction.

Agrium and PotashCorp disclaim any intention or obligation to update or revise any forward–looking statements in this press release as a result of new information or future events, except as may be required under applicable U.S. federal securities laws or applicable Canadian securities legislation.

Autographed guitars by Dave Matthews Band and other music artists raise $44,000 to build smart home for Naval Veteran

COLUMBIA, MO—(Marketwired – November 07, 2016) – A company–wide auction at Veterans United Home Loans raised more than $44,000 to help build a smart home for a triple amputee Veteran. The event gave the company's 2,100 employees the opportunity to bid on and win autographed guitars by some of the biggest names in music, including Dave Matthews Band, Gwen Stefani and Kenny Chesney.

Several artists who appeared this summer at the Veterans United Home Loans Amphitheater in Virginia Beach, Virginia, signed guitars to help raise money to build a specially–adapted smart home for Navy Veteran Andrew Bottrell. The home will be built in San Diego by the Gary Sinise Foundation's R.I.S.E. program (Restoring Independence Supporting Empowerment), which provides mortgage–free homes customized specifically to the needs of severely wounded Veterans.

“To raise more than $44,000 from employee donations far exceeded our expectations,” said Kris Farmer, chief marketing officer at Veterans United. “Nearly every artist who played at Veterans United Home Loans Amphitheater this summer signed a guitar. I'm extremely humbled by the number of artists who were willing to participate.”

Bottrell was deployed to Afghanistan in July 2011 with Seal Team 10. On Oct. 1, 2011, his vehicle was struck by an improvised explosive device. He suffered extreme injuries, which led to a double leg and left arm amputation.

“I am incredibly honored the employees at Veterans United Home Loans chose me as the beneficiary of this fundraiser,” Bottrell said. “I am eternally grateful to them and the Gary Sinise Foundation for this amazing gift and for everything they do for the Veteran community.”

Auctioned guitars were autographed by Brad Paisley, Collective Soul, Darius Rucker, Dave Mason, Dave Matthews Band, Dierks Bentley, Dixie Chicks, Doobie Brothers, Florida Georgia Line, Goo Goo Dolls, Gwen Stefani, Jason Aldean, Keith Urban, Kenny Chesney, Luke Bryan, Miranda Lambert, Rascal Flatts and Toby Keith.

The donation from the employee auction is in addition to a $300,000 gift Veterans United Foundation made in February toward the construction.

About Veterans United Foundation

Veterans United Foundation is supported entirely by the employees of Veterans United Home Loans. The foundation is committed to enhancing the lives of Veterans and military families nationwide, by supporting nonprofit organizations that strengthen local communities and honor the sacrifices of those who served our country. The foundation also provides individual donations to current and former military members in need. Employees have given more than $20 million to the foundation since its founding in November 2011. Learn more at

ZIVO Bioscience, Inc. Annual Shareholder Meeting and Conference Call Slated for November 9, 2016 in Detroit, Michigan

KEEGO HARBOR, MI—(Marketwired – Nov 7, 2016) –  ZIVO Bioscience, Inc., (OTCQB: ZIVO) a Michigan–based biotech firm, invites shareholders, analysts and partners to its annual shareholder meeting on Wednesday, November 9, 2016, beginning at 10:00AM EST. The event will be held at the Westin Hotel located within the Detroit Metropolitan Airport (DTW) Midfield Terminal building, in the meeting room levels below the main atrium. The Company's management will share its progress on various research and product development efforts over the past year.

Over the last 4 years, the Company has engaged in a wide–ranging research and validation program to substantiate the efficacy of its algal–based natural products in various applications, with a focus on bovine udder health, canine joint health and healthy cholesterol balance in humans. Based on encouraging results from various studies, the Company is now looking to commercialize its product platform.

The shareholder meeting will begin promptly at 10:00AM EST on Wednesday, November 9th. Those who cannot attend in person are invited to call in to the conference line provided for this event.

ZIVO Bioscience, Inc. Annual Shareholder Meeting and Conference Call
Conference Date: November 9, 2016
Conference Start Time: 10:00 AM Eastern Standard Time
Participants are encouraged to call in 5–10 minutes prior to start
Participant Dial–In Numbers:
TOLL–FREE 1–877–627–6585

A replay of the Meeting and Conference Call will be available as follows:
Replay Dial–In Numbers:
TOLL–FREE 1–844–512–2921
From: November 9, 2016 @ 1:00 PM Eastern Standard Time
To: November 23, 2016 @ 11:59 PM Eastern Standard Time
Replay PIN Number: 9559607

About ZIVO Bioscience, Inc.
ZIVO Bioscience, Inc. (OTCQB: ZIVO) is a Michigan–based biotech company engaged in the investigation of the health benefits of bioactive compounds derived from its proprietary algal cultures, and the development of natural bioactive compounds for use as dietary supplements and food ingredients, as well as biologics and synthetic candidates for medicinal and pharmaceutical applications in humans and animals, specifically focused on autoimmune modulation.

Safe Harbor Statement
Except for any historical information, the matters discussed in this press release contain forward–looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward–looking statements involve risks and uncertainties. A number of factors could cause actual results to differ from those indicated in the forward–looking statements, including the timing of completion of a trial, actual future clinical trial results being different than the results the company has obtained to date, and the company's ability to secure funding. Such statements are subject to a number of assumptions, risks and uncertainties. Readers are cautioned that such statements are not guarantees of future performance and those actual results or developments may differ materially from those set forth in the forward–looking statements. The company undertakes no obligation to publicly update or revise forward–looking statements, whether as a result of new information or otherwise.

Applied DNA Sciences Closes on $5 Million Private Placement

STONY BROOK, NY—(Marketwired – November 07, 2016) – Applied DNA Sciences, Inc. (“Applied DNA” or the “Company”) (NASDAQ: APDN), a provider of DNA–based supply chain, anti–counterfeiting, authentication, genotyping and anti–theft technologies, today announced that it has closed on a private placement pursuant to a securities purchase agreement with a single healthcare dedicated institutional investor to purchase $5 million of common stock and warrants at a combined price of $2.20 per share of common stock and warrant. In the private placement, Applied DNA sold 2,272,727 shares of its common stock and warrants to purchase 2,272,727 shares of its common stock. The warrants have the same terms as the Company's existing publicly traded warrants (NASDAQ: APDNW) with an exercise price of $3.50 per share and an expiration date of November 20, 2019.

The Company has agreed to file a registration statement providing for the resale of these securities on Form S–3 by December 7, 2016. Upon effectiveness of the registration statement, it is expected that the common stock and warrants issued in the private placement will be freely tradeable on The NASDAQ Capital Market under the symbols “APDN” and “APDNW”, respectively.

The aggregate gross proceeds to the Company from the private placement were $5 million before deducting the placement agent's fee and other offering expenses.

The company intends to use the aggregate net proceeds from the private placement for general corporate purposes, including working capital, capital expenditures, business development and research and development.

Maxim Group LLC acted as Lead Placement Agent and Imperial Capital, LLC acted as Co–Placement Agent.

This press release shall not constitute an offer to sell, or a solicitation of an offer to buy the securities nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Any offering of the securities pursuant to the resale registration statement will only be by means of a prospectus. The terms and conditions of the transactions described in this press release are qualified in their entirety by reference to the Form 8–K filed with the SEC on November 3, 2016 and the transaction documents filed as exhibits thereto. Additional information can be found in the Company's filings with the SEC available at and on the Company's website at

About Applied DNA Sciences
We make life real and safe by providing botanical–DNA based security and authentication solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. Our patented DNA–based solutions can be used to identify, tag, track, and trace products, to help assure authenticity, traceability and quality of products. SigNature® DNA describes the platform ingredient that is at the heart of a family of uncopyable, security and authentication solutions such as SigNature® T and fiberTyping®, targeted toward textiles and apparel, DNAnet®, for anti–theft and loss prevention, and digitalDNA®, providing powerful track and trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. We are also engaged in the large–scale production of specific DNA sequences using the polymerase chain reaction.

Go to for more information, events and to learn more about how Applied DNA Sciences makes life real and safe. Common stock listed on NASDAQ under the symbol APDN, and warrants are listed under the symbol APDNW.

Forward–Looking Statements

The statements made by APDN in this press release may be “forward–looking” in nature within the meaning of the Private Securities Litigation Act of 1995. Forward–looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10–K filed on December 14, 2015,and our subsequent quarterly reports on Form 10–Q filed on February 10, 2016, May 12, 2016 and August 11, 2016 which are available at APDN undertakes no obligation to update publicly any forward–looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.

KBR Joint Venture Awarded Another Program Management Contract in Azerbaijan

HOUSTON, TX—(Marketwired – November 07, 2016) – KBR, Inc. (NYSE: KBR) announced today that its joint venture with SOCAR was awarded a second program management consultancy contract for the Azerikimya Production Union of the State Oil Company of Azerbaijan.

This award marks the second award to the joint venture, SOCAR–KBR Limited Liability Company (SOCAR–KBR LLC), since its inception in mid–2015. SOCAR–KBR LLC was formed to help further Azerbaijan's ambition for creating a world–class Azerbaijan based engineering company. SOCAR–KBR LLC will build upon KBR's more than 20 years of project experience in Azerbaijan to perform program management services from its established offices in Baku for the Azerikimya modernization project.

Addressing the audience at the contract signing ceremony, Rovnag Abdullayev, SOCAR's President, said, “The modernization project will make it possible to increase the production facilities at Azerikimya, ensure the supply of raw materials to polyethylene and polypropylene production installations and to meet the demand in the country. It will also increase the country's export potential, enhance the security of the technological process and the quality of raw materials and finished products.”

“SOCAR–KBR LLC, combines KBR's extensive experience in the oil and gas sector with SOCAR's strong vision and leadership in the region to perform the program management role for this key project for Azerikimya,” said Jan Egil Braendeland, SOCAR KBR LLC Board Member and KBR Executive Vice President of Global Sales. “We have passionate and talented Azerbaijani and international team members who are dedicated to Azerbaijan and our partner SOCAR and I am confident SOCAR KBR LLC will deliver successfully on this project and others in region,” Braendeland continued.

The value of the contract is undisclosed and will be booked into the backlog of unfilled orders for KBR's Engineering & Construction business segment in Q4 of 2016.

About KBR, Inc.

KBR is a global provider of differentiated professional services and technologies across the asset and program life cycle within the Hydrocarbons and Government Services Sectors. KBR employs over 31,000 people worldwide, with customers in more than 80 countries, and operations in 40 countries, across three synergistic global businesses:

  • Government Services, serving government customers globally, including capabilities that cover the full life–cycle of defense, space, aviation and other government programs and missions from research and development, through systems engineering, test and evaluation, program management, to operations, maintenance, and field logistics
  • Technology & Consulting, including proprietary technology focused on the monetization of hydrocarbons (especially natural gas and natural gas liquids) in ethylene and petrochemicals; ammonia, nitric acid and fertilizers; oil refining; gasification; oil and gas consulting; integrity management; naval architecture and proprietary hulls; and downstream consulting
  • Engineering & Construction, including onshore oil and gas; LNG (liquefaction and regasification)/GTL; oil refining; petrochemicals; chemicals; fertilizers; differentiated EPC; maintenance services (Brown & Root Industrial Services); offshore oil and gas (shallow–water, deep–water, subsea); floating solutions (FPU, FPSO, FLNG & FSRU) and program management

KBR is proud to work with its customers across the globe to provide technology, value–added services, integrated EPC delivery and long term operations and maintenance services to ensure consistent delivery with predictable results. At KBR, We Deliver.


Forward Looking Statement

The statements in this press release that are not historical statements, including statements regarding future financial performance, are forward–looking statements within the meaning of the federal securities laws. These statements are subject to numerous risks and uncertainties, many of which are beyond the company's control that could cause actual results to differ materially from the results expressed or implied by the statements. These risks and uncertainties include, but are not limited to: the outcome of and the publicity surrounding audits and investigations by domestic and foreign government agencies and legislative bodies; potential adverse proceedings by such agencies and potential adverse results and consequences from such proceedings; the scope and enforceability of the company's indemnities from its former parent; changes in capital spending by the company's customers; the company's ability to obtain contracts from existing and new customers and perform under those contracts; structural changes in the industries in which the company operates; escalating costs associated with and the performance of fixed–fee projects and the company's ability to control its cost under its contracts; claims negotiations and contract disputes with the company's customers; changes in the demand for or price of oil and/or natural gas; protection of intellectual property rights; compliance with environmental laws; changes in government regulations and regulatory requirements; compliance with laws related to income taxes; unsettled political conditions, war and the effects of terrorism; foreign operations and foreign exchange rates and controls; the development and installation of financial systems; increased competition for employees; the ability to successfully complete and integrate acquisitions; and operations of joint ventures, including joint ventures that are not controlled by the company.

KBR's most recently filed Annual Report on Form 10–K, any subsequent Form 10–Qs and 8–Ks, and other Securities and Exchange Commission filings discuss some of the important risk factors that KBR has identified that may affect the business, results of operations and financial condition. Except as required by law, KBR undertakes no obligation to revise or update publicly any forward–looking statements for any reason.